What did Becton, Dickinson and Company pay for Edwards Lifesciences Critical Care Business?

Becton, Dickinson and Company acquired Edwards Lifesciences Critical Care Business for $3.91B in 2024, equivalent to 4.40x revenue. Target revenue was approximately $900.0M.

What does Edwards Lifesciences Critical Care Business do?

Edwards Lifesciences Critical Care Business is a medical devices business.

What multiple did Becton, Dickinson and Company pay for Edwards Lifesciences Critical Care Business?

4.40x revenue, based on disclosed deal value of $3.91B and disclosed financials.

M&A TRANSACTION · 2024

Edwards Lifesciences Critical Care Business acquired by Becton, Dickinson and Company

$3.91B· 4.40x revenue

Target

Edwards Lifesciences Critical Care Business

Acquirer

Becton, Dickinson and Company

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$900.0M

EBITDA

—

Deal Value

$3.91B

EV/EBITDA

—

Context

This $3.91B acquisition of Edwards Lifesciences Critical Care Business by Becton, Dickinson and Company sits in the medical devices sub-vertical. Becton, Dickinson and Company is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Edwards Lifesciences Critical Care Business acquisition.

Citation: ExitValue.ai. (2024). Edwards Lifesciences Critical Care Business acquired by Becton, Dickinson and Company. https://exitvalue.ai/deals/edwards-lifesciences-critical-care-business-acquired-by-becton-dickinson-and-company-hc-2024-0029